Cardiovascular magnetic resonance for the evaluation of patients with cardiovascular disease: An overview of current indications, limitations, and procedures

Wilkins, 2017 Ritchie, 2018, Our world in data Pennell, 2010, Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia, Blood, 115, 2364, 10.1182/blood-2009-04-217455 Mavrogeni, 2022, Cardiovascular magnetic resonance in autoimmune rheumatic diseases: a clinical consensus document by the European Association of Cardiovascular Imaging, Eur Heart J Cardiovasc Imaging, 23, e308, 10.1093/ehjci/jeac134 Liu, 2021, Cardiovascular Magnetic Resonance Imaging and Heart Failure, Curr Cardiol Rep, 23, 35, 10.1007/s11886-021-01464-9 Alraies, 2015, Usefulness of cardiac magnetic resonance-guided management in patients with recurrent pericarditis, Am J Cardiol, 115, 542, 10.1016/j.amjcard.2014.11.041 Rosmini, 2019, Characterisation of pleural and pericardial effusions with T1 mapping, 20 Vidalakis, 2020, CMR in Pericardial Diseases - an Update, Curr Cardiovasc Imaging Rep, 13, 14, 10.1007/s12410-020-9535-z Cosyns, 2015, Eur Heart J Cardiovasc Imaging, 16, 12, 10.1093/ehjci/jeu128 Geske, 2016, Differentiation of constriction and restriction: complex cardiovascular hemodynamics, J Am Coll Cardiol, 68, 2329, 10.1016/j.jacc.2016.08.050 Glower, 2016, Sticking points in magnetic resonance diagnosis of constrictive pericarditis, J Thorac Cardiovasc Surg, 151, 1356, 10.1016/j.jtcvs.2015.12.042 Francone, 2006, Assessment of ventricular coupling with real-time cine MRI and its value to differentiate constrictive pericarditis from restrictive cardiomyopathy, Eur Radiol, 16, 944, 10.1007/s00330-005-0009-0 Mavrogeni, 2016, Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use, Int J Cardiol, 217, 135, 10.1016/j.ijcard.2016.04.158 Srichai, 2006, Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation, Am Heart J, 152, 75, 10.1016/j.ahj.2005.08.021 Rosmini, 2021, Characterisation of pleural and pericardial effusions with T1 mapping, Eur Heart J Cardio Vascul Imag, jeab128 Giri, 2012, Myocardial T₂ mapping with respiratory navigator and automatic nonrigid motion correction, Magn Reson Med, 68, 1570, 10.1002/mrm.24139 Wassmuth, 2013, Variability and homogeneity of cardiovascular magnetic resonance myocardial T2-mapping in volunteers compared to patients with edema, J Cardiovasc Magn Reson, 15, 10.1186/1532-429X-15-27 Granitz, 2019, Comparison of native myocardial T1 and T2 mapping at 1.5T and 3T in healthy volunteers, Wien Klin Wochenschr, 131, 143, 10.1007/s00508-018-1411-3 Patel, 2021, Stress Cardiac Magnetic Resonance Myocardial Perfusion Imaging: JACC Review Topic of the Week, J Am Coll Cardiol, 78, 1655, 10.1016/j.jacc.2021.08.022 Levelt, 2017, Adenosine stress CMR T1-mapping detects early microvascular dysfunction in patients with type 2 diabetes mellitus without obstructive coronary artery disease, J Cardiovasc Magn Reson, 19, 81, 10.1186/s12968-017-0397-8 Monmeneu Menadas, 2016, Pharmacological stress cardiovascular magnetic resonance: feasibility and safety in a large multicentre prospective registry, Eur Heart J Cardiovasc Imaging, 17, 308, 10.1093/ehjci/jev153 Agrawal, 2021, Impaired myocardial perfusion on stress CMR correlates with invasive FFR in children with coronary anomalies, J Invasive Cardiol, 33, E45 Moon, 2013, Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement, J Cardiovasc Magn Reson, 15, 92, 10.1186/1532-429X-15-92 Rosmini, 2018, Myocardial native T1 and extracellular volume with healthy ageing and gender, Eur Heart J Cardiovasc Imaging, 19, 615, 10.1093/ehjci/jey034 Li, 2022, T1 Mapping and Extracellular Volume Fraction in Dilated Cardiomyopathy: A Prognosis Study, JACC Cardiovasc Imaging, 15, 578, 10.1016/j.jcmg.2021.07.023 Xu, 2020, MRI T1 mapping in hypertrophic cardiomyopathy: evaluation in patients without late gadolinium enhancement and hemodynamic obstruction, Radiology, 294, 275, 10.1148/radiol.2019190651 Kitkungvan, 2021, Extracellular volume in primary mitral regurgitation, JACC Cardiovasc Imaging, 14, 1146, 10.1016/j.jcmg.2020.10.010 Sibley, 2012, T1 mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy, Radiology, 265, 724, 10.1148/radiol.12112721 Barison, 2015, Early myocardial and skeletal muscle interstitial remodeling in systemic sclerosis: insights from extracellular volume quantification using cardio-vascular magnetic resonance, Eur Heart J Cardiovasc Imaging, 16, 74, 10.1093/ehjci/jeu167 Teixeira, 2016, Comparison of different cardiovascular magnetic resonance sequences for native myocardial T1 mapping at 3T, J Cardiovasc Magn Reson, 18, 65, 10.1186/s12968-016-0286-6 Liu, 2012, Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials, J Cardiovasc Magn Reson, 14, 90, 10.1186/1532-429X-14-90 Raman, 2012, CMR in inflammatory vasculitis, J Cardiovasc Magn Reson, 14, 82, 10.1186/1532-429X-14-82 Leiner, 2020, SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance, J Cardiovasc Magn Reson, 22, 76, 10.1186/s12968-020-00682-4 Schwenk, 2010, Ferumoxytol: a new intravenous iron preparation for the treatment of iron deficiency anemia in patients with chronic kidney disease, Pharmacotherapy, 30, 70, 10.1592/phco.30.1.70 Bashir, 2015, Emerging applications for ferumoxytol as a contrast agent in MRI, J Magn Reson Imag, 41, 884, 10.1002/jmri.24691 Androulakis, 2022, Magnetic resonance coronary angiography in the era of multimodality imaging, Clin Radiol, 77, e489, 10.1016/j.crad.2022.03.008 Mavrogeni, 2004, Magnetic resonance angiography is equivalent to X-ray coronary angiography for the evaluation of coronary arteries in Kawasaki disease, J Am Coll Cardiol, 43, 649, 10.1016/j.jacc.2003.08.052 Valsangiacomo Buechel, 2009, Feasibility of perfusion cardiovascular magnetic resonance in paediatric patients, J Cardiovasc Magn Reson, 11, 51, 10.1186/1532-429X-11-51 Simonneau, 2019, Haemodynamic definitions and updated clinical classification of pulmonary hypertension, Eur Respir J, 53, 10.1183/13993003.01913-2018 Benoit Lechartier, Ari Chaouat, John-David Aubert and Juerg Schwitter on behalf of the Swiss Society for Pulmonary Hypertension (SSPH). Magnetic resonance imaging in pulmonary hypertension, an overview of current applications and future perspectives. Swiss Med Wkly . Alabed, 2020, Cardiac magnetic resonance in pulmonary hypertension-an update, Curr Cardiovasc Imaging Rep, 13, 30, 10.1007/s12410-020-09550-2 Johns, 2019, Diagnosis of pulmonary hypertension with cardiac MRI: derivation and validation of regression models, Radiology, 290, 61, 10.1148/radiol.2018180603 Cerne, 2021, Evaluation of pulmonary hypertension using 4D flow MRI, J Magn Reson Imag Gerber, 2020 Lopez-Mattei, 2013, The role of cardiac magnetic resonance in valvular heart disease, Methodist Debakey Cardiovasc J, 9, 142, 10.14797/mdcj-9-3-142 Myerson, 2021, CMR in evaluating valvular heart disease: diagnosis, severity, and outcomes, JACC Cardiovasc Imaging, 14, 2020, 10.1016/j.jcmg.2020.09.029 Bing, 2019, Imaging and impact of myocardial fibrosis in aortic stenosis, JACC Cardiovasc Imaging, 12, 283, 10.1016/j.jcmg.2018.11.026 Anderson, 2001, Cardiovascular T2-star (T2∗) magnetic resonance for the early diagnosis of myocardial iron overload, Eur Heart J, 22, 2171, 10.1053/euhj.2001.2822 Hwang, 2016, Cardiac implantable electronic device safety during magnetic resonance imaging, Korean Circ J, 46, 804, 10.4070/kcj.2016.46.6.804 Moschetti, 2022, Cost-minimization analysis for cardiac revascularization in 12 health care systems based on the EuroCMR/SPINS Registries, JACC Cardiovasc Imaging, 10.1016/j.jcmg.2021.11.008 Kramer, 2013, Society for cardiovascular magnetic resonance board of trustees task force on standardized protocols. standardized cardiovascular magnetic resonance (CMR) protocols 2013 update, J Cardiovasc Magn Reson, 15, 91, 10.1186/1532-429X-15-91 Menacho Medina, 2021, Noninvasive rapid cardiac magnetic resonance for the assessment of cardiomyopathies in low-middle income countries, Expert Rev Cardiovasc Ther, 19, 387, 10.1080/14779072.2021.1915130 Almeida, 2021, Eur Heart J Cardiovasc Imaging, 22, e97, 10.1093/ehjci/jeab053 Jaarsma, 2012, J Am Coll Cardiol, 59, 1719, 10.1016/j.jacc.2011.12.040 Keil, 2021, CMR-based risk stratification of sudden cardiac death and use of implantable cardioverter-defibrillator in non-ischemic cardiomyopathy, Int J Mol Sci, 22, 7115, 10.3390/ijms22137115 Schwitter, 2012, Eur Heart J, 34, 775, 10.1093/eurheartj/ehs022 Levelt, 2017, Adenosine stress CMR T1-mapping detects early microvascular dysfunction in patients with type 2 diabetes mellitus without obstructive coronary artery disease, J Cardiovasc Magn Reson, 19, 81, 10.1186/s12968-017-0397-8 Ferreira, 2018, Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations, J Am Coll Cardiol, 72, 3158, 10.1016/j.jacc.2018.09.072 Qayyum, 2015, Measuring myocardial perfusion: the role of PET, MRI and CT, Clin Radiol, 70, 576, 10.1016/j.crad.2014.12.017 Mavrogeni, 2016, How to approach the great mimic? Improving techniques for the diagnosis of myocarditis, Expert Rev Cardiovasc Ther, 14, 105, 10.1586/14779072.2016.1110486 Fratz, 2013, Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease, J Cardiovasc Magn Reson, 15, 51, 10.1186/1532-429X-15-51